{"nct_id":"NCT01702285","title":"Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Orally Administered CUDC-101 in Cancer Patients","status":"TERMINATED","status_verified_date":"2018-02","start_date":"2012-09","start_date_type":null,"primary_completion_date":"2012-12","primary_completion_date_type":"ACTUAL","completion_date":"2012-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["CRIS"]}